Report Detail
Global Hemoperfusion production Market Growth 2019-2024
- RnM2938517 |
- 13 February, 2019 |
- Global |
- 130 Pages |
- LPI(LP Information) |
- Other
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
In 2017, China consumption volume reached 1907.5 K Units, due to the bigger demand of downstream applications and the larger population and policy support; while Europe consumed 725.4 K Units and Japan consumed 362.7 K Units.
The major raw materials for hemoperfusion are polypropylene, polycarbonate, membrane materials, activated carbon, etc. Fluctuations in the price of the upstream product will impact on the production cost of hemoperfusion, and then impact the price of hemoperfusion. The production cost of hemoperfusion is also an important factor which could impact the price of hemoperfusion.
According to this study, over the next five years the Hemoperfusion production market will register a 13.4% CAGR in terms of revenue, the global market size will reach US$ 690 million by 2024, from US$ 320 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hemoperfusion production business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemoperfusion production market by product type, application, key manufacturers and key regions and countries.
This study considers the Hemoperfusion production value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Resin Adsorption
Activated Carbon Adsorption
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Overdose
Specific Intoxications
Certain Autoimmune Diseases
Hepatic Encephalopathy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Jafron Biomedical
Baxter (Gambro)
Biosun Medical
Toray Medical
Asahi-Kasei
Kaneka
Zibo Kangbei
Aier
Cytosorbents
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hemoperfusion production consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hemoperfusion production market by identifying its various subsegments.
Focuses on the key global Hemoperfusion production manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hemoperfusion production with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hemoperfusion production submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Hemoperfusion production Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Hemoperfusion production Consumption 2014-2024
- 2.1.2 Hemoperfusion production Consumption CAGR by Region
- 2.2 Hemoperfusion production Segment by Type
- 2.2.1 Resin Adsorption
- 2.2.2 Activated Carbon Adsorption
- 2.2.3 Others
- 2.3 Hemoperfusion production Consumption by Type
- 2.3.1 Global Hemoperfusion production Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Hemoperfusion production Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Hemoperfusion production Sale Price by Type (2014-2019)
- 2.4 Hemoperfusion production Segment by Application
- 2.4.1 Overdose
- 2.4.2 Specific Intoxications
- 2.4.3 Certain Autoimmune Diseases
- 2.4.4 Hepatic Encephalopathy
- 2.4.5 Others
- 2.5 Hemoperfusion production Consumption by Application
- 2.5.1 Global Hemoperfusion production Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Hemoperfusion production Value and Market Share by Application (2014-2019)
- 2.5.3 Global Hemoperfusion production Sale Price by Application (2014-2019)
3 Global Hemoperfusion production by Players
- 3.1 Global Hemoperfusion production Sales Market Share by Players
- 3.1.1 Global Hemoperfusion production Sales by Players (2017-2019)
- 3.1.2 Global Hemoperfusion production Sales Market Share by Players (2017-2019)
- 3.2 Global Hemoperfusion production Revenue Market Share by Players
- 3.2.1 Global Hemoperfusion production Revenue by Players (2017-2019)
- 3.2.2 Global Hemoperfusion production Revenue Market Share by Players (2017-2019)
- 3.3 Global Hemoperfusion production Sale Price by Players
- 3.4 Global Hemoperfusion production Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Hemoperfusion production Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Hemoperfusion production Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Hemoperfusion production by Regions
- 4.1 Hemoperfusion production by Regions
- 4.1.1 Global Hemoperfusion production Consumption by Regions
- 4.1.2 Global Hemoperfusion production Value by Regions
- 4.2 Americas Hemoperfusion production Consumption Growth
- 4.3 APAC Hemoperfusion production Consumption Growth
- 4.4 Europe Hemoperfusion production Consumption Growth
- 4.5 Middle East & Africa Hemoperfusion production Consumption Growth
5 Americas
- 5.1 Americas Hemoperfusion production Consumption by Countries
- 5.1.1 Americas Hemoperfusion production Consumption by Countries (2014-2019)
- 5.1.2 Americas Hemoperfusion production Value by Countries (2014-2019)
- 5.2 Americas Hemoperfusion production Consumption by Type
- 5.3 Americas Hemoperfusion production Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Hemoperfusion production Consumption by Countries
- 6.1.1 APAC Hemoperfusion production Consumption by Countries (2014-2019)
- 6.1.2 APAC Hemoperfusion production Value by Countries (2014-2019)
- 6.2 APAC Hemoperfusion production Consumption by Type
- 6.3 APAC Hemoperfusion production Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Hemoperfusion production by Countries
- 7.1.1 Europe Hemoperfusion production Consumption by Countries (2014-2019)
- 7.1.2 Europe Hemoperfusion production Value by Countries (2014-2019)
- 7.2 Europe Hemoperfusion production Consumption by Type
- 7.3 Europe Hemoperfusion production Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Hemoperfusion production by Countries
- 8.1.1 Middle East & Africa Hemoperfusion production Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Hemoperfusion production Value by Countries (2014-2019)
- 8.2 Middle East & Africa Hemoperfusion production Consumption by Type
- 8.3 Middle East & Africa Hemoperfusion production Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Hemoperfusion production Distributors
- 10.3 Hemoperfusion production Customer
11 Global Hemoperfusion production Market Forecast
- 11.1 Global Hemoperfusion production Consumption Forecast (2019-2024)
- 11.2 Global Hemoperfusion production Forecast by Regions
- 11.2.1 Global Hemoperfusion production Forecast by Regions (2019-2024)
- 11.2.2 Global Hemoperfusion production Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Hemoperfusion production Forecast by Type
- 11.8 Global Hemoperfusion production Forecast by Application
12 Key Players Analysis
- 12.1 Jafron Biomedical
- 12.1.1 Company Details
- 12.1.2 Hemoperfusion production Product Offered
- 12.1.3 Jafron Biomedical Hemoperfusion production Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Jafron Biomedical News
- 12.2 Baxter (Gambro)
- 12.2.1 Company Details
- 12.2.2 Hemoperfusion production Product Offered
- 12.2.3 Baxter (Gambro) Hemoperfusion production Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Baxter (Gambro) News
- 12.3 Biosun Medical
- 12.3.1 Company Details
- 12.3.2 Hemoperfusion production Product Offered
- 12.3.3 Biosun Medical Hemoperfusion production Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Biosun Medical News
- 12.4 Toray Medical
- 12.4.1 Company Details
- 12.4.2 Hemoperfusion production Product Offered
- 12.4.3 Toray Medical Hemoperfusion production Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Toray Medical News
- 12.5 Asahi-Kasei
- 12.5.1 Company Details
- 12.5.2 Hemoperfusion production Product Offered
- 12.5.3 Asahi-Kasei Hemoperfusion production Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Asahi-Kasei News
- 12.6 Kaneka
- 12.6.1 Company Details
- 12.6.2 Hemoperfusion production Product Offered
- 12.6.3 Kaneka Hemoperfusion production Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Kaneka News
- 12.7 Zibo Kangbei
- 12.7.1 Company Details
- 12.7.2 Hemoperfusion production Product Offered
- 12.7.3 Zibo Kangbei Hemoperfusion production Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Zibo Kangbei News
- 12.8 Aier
- 12.8.1 Company Details
- 12.8.2 Hemoperfusion production Product Offered
- 12.8.3 Aier Hemoperfusion production Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Aier News
- 12.9 Cytosorbents
- 12.9.1 Company Details
- 12.9.2 Hemoperfusion production Product Offered
- 12.9.3 Cytosorbents Hemoperfusion production Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Cytosorbents News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Hemoperfusion production . Industry analysis & Market Report on Hemoperfusion production is a syndicated market report, published as Global Hemoperfusion production Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Hemoperfusion production market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
